Table 2 Associations of MND1 expression with clinic-pathological features estimated by logistic regression analysis.

From: Genetic network and gene set enrichment analyses identify MND1 as potential diagnostic and therapeutic target gene for lung adenocarcinoma

Clinical characteristics

Total (n)

OR for the elevated MND1 expression

p

Stage (III vs. I)

335

1.68 (1.01–2.83)

0.046

Distant metastasis (positive vs. negative)

348

1.73 (0.75–4.22)

0.209

Age (continuous)

458

0.37 (0.14–0.87)

0.028

Lymph node metastasis (positive vs. negative)

465

1.50 (0.93–2.43)

0.098

Gender (male vs. female)

477

1.34 (0.94–1.93)

0.109

  1. Categorical dependent variable, greater or less than the median expression level.
Back to article page